Editorial on “The genomic landscape of TERT promoter wildtype-IDHwildtype glioblastoma”

In 2016, with the publication of the novel guidelines for the classification of the central nervous system (CNS) tumours by the World Health Organization (WHO) (1), there was a paradigm shift in the classical diagnosis, mainly based in microscopy, by the integration of molecular markers in the novel stratification.